Related Experiment Videos
Haemochromatosis
D H Crawford1, B A Leggett, L W Powell
1Department of Gastroenterology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Insights
Hereditary haemochromatosis is a common genetic disorder affecting Caucasians. Early diagnosis through genetic testing and awareness can improve patient outcomes and therapy.
Area of Science:
- Genetics
- Hepatology
- Internal Medicine
Background:
- Hereditary haemochromatosis is a prevalent inherited disorder in Caucasian populations.
- The genetic defect, while the gene is cloned (MHC non-classical class I family), remains incompletely understood.
- Iron loading is influenced by various factors, including blood loss and genetic predisposition.
Purpose of the Study:
- To highlight the significance of hereditary haemochromatosis as a common inherited disorder.
- To emphasize the role of genetic factors and iron metabolism in disease progression.
- To advocate for earlier diagnosis and treatment through increased awareness and genetic testing.
Main Methods:
- Review of existing literature on hereditary haemochromatosis.
- Discussion of genetic factors, including the cloned haemochromatosis gene.
- Analysis of factors influencing iron loading and disease severity.
Main Results:
- Disease frequency is 1:300-400, with a 10% carrier frequency in Caucasians.
- Hepatic iron concentration is a key determinant of survival; levels >400 mumol/g dry weight correlate with cirrhosis.
- Cirrhosis in haemochromatosis patients increases the risk of hepatocellular carcinoma.
Conclusions:
- Increased awareness and genetic testing for mutations like C282Y are crucial for early diagnosis.
- Timely diagnosis and therapy can mitigate severe complications such as liver cirrhosis and cancer.
- Understanding the genetic basis and influencing factors is vital for managing hereditary haemochromatosis.
Abstract:
Primary, hereditary or genetic haemochromatosis is one of the most common inherited disorders in a Caucasian populations with a disease frequency of 1:300-400 and a carrier frequency of approximately 10%. The basic genetic defect remains unknown, although the haemochromatosis gene has now been cloned and is known to be a member of the MHC non-classical class I family. Many factors--environmental, genetic and non-genetic in nature--influence the degree of iron loading in affected individuals. In particular, pathological and physiological blood loss influence iron stores in haemochromatosis. The iron concentration in the liver is an important determinant of survival because a hepatic iron concentration in excess of 400 mumol/g dry weight is usually associated with cirrhosis. Patients with cirrhosis secondary to haemochromatosis are at risk of hepatocellular carcinoma. The combination of improved awareness of the disease and the appropriate use of genetic testing for the common C282Y mutation should lead to earlier diagnosis and therapy.